Multicenter studies with a longitudinal follow-up should be designed to collect a high number of patients affected by CRB1-associated retinal dystrophy to ascertain the natural history evolution, investigating the correlation between dystrophy severity and vascular damage. The gene discussed is CRB1; the disease is Retinal dystrophy.